| Gene Symbol | RASA2 |
|---|---|
| Full Name | RAS GTPase-Activating Protein 2 |
| Chromosomal Location | 3q13.2 |
| NCBI Gene ID | [10621](https://www.ncbi.nlm.nih.gov/gene/10621) |
| OMIM | [607434](https://www.omim.org/entry/607434) |
| Ensembl ID | [ENSG00000155903](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155903) |
| UniProt ID | [Q9Y2T3](https://www.uniprot.org/uniprot/Q9Y2T3) |
| Protein Length | 878 amino acids |
| Molecular Weight | ~95 kDa |
| Associated Diseases | Cancer, potential neurodegenerative implications, vascular cognitive impairment |
RASA2 (RAS GTPase-Activating Protein 2) is a member of the p120GAP (GTPase-activating protein) family that functions as a negative regulator of RAS signaling. As a RAS-GAP, RASA2 promotes the intrinsic GTP hydrolysis activity of RAS proteins, converting them from the active GTP-bound state to the inactive GDP-bound state[1].
RAS proteins are small GTPases that function as molecular switches in multiple cellular signaling pathways controlling cell proliferation, differentiation, survival, and synaptic plasticity. The balance between RAS activation and inactivation is critical for normal cellular function, and dysregulation of this balance has been implicated in various diseases including cancer and potentially neurodegenerative disorders[2][3].
In the nervous system, RASA2 plays important roles in modulating RAS-RAF-MEK-ERK and PI3K-AKT signaling pathways, which are essential for synaptic plasticity, learning, memory, and neuronal survival. Altered RAS signaling has been increasingly recognized as a contributor to neurodegenerative disease pathogenesis[4][5].
RASA2 functions as a classical RAS GTPase-activating protein with the following mechanism:
The GAP domain of RASA2 contains the characteristic catalytic arginine finger that inserts into the active site of RAS to stabilize the transition state and accelerate GTP hydrolysis by approximately 10^5-fold compared to the intrinsic rate[2:1].
RASA2 contains several functional domains:
| Domain | Function |
|---|---|
| N-terminal SH2 domain | Binds to phosphotyrosine-containing motifs, targeting RASA2 to activated receptor tyrosine kinases |
| N-terminal SH3 domain | Proline-rich region binding, mediates protein-protein interactions |
| GAP domain | Catalytic domain providing GTPase-activating function |
| C-terminal region | Regulatory and targeting functions |
The SH2-SH3 unit allows RASA2 to be recruited to activated receptor tyrosine kinases and other signaling complexes, ensuring spatial and temporal regulation of RAS activity at specific cellular locations[6].
Beyond its catalytic GAP activity, RASA2 also serves regulatory functions:
RASA2 critically regulates synaptic plasticity—the ability of synapses to strengthen or weaken in response to activity. Key functions include:
The RAS-ERK pathway is essential for memory formation and consolidation. RASA2 contributes to:
During development, RASA2 regulates:
RASA2 modulates several key neuronal signaling pathways:
RASA2 and RAS signaling are implicated in Alzheimer's disease through several mechanisms:
In Alzheimer's disease, synaptic failure is a hallmark. Altered RAS signaling through RASA2 dysregulation may contribute to:
Amyloid-beta can directly affect RAS signaling pathways:
Tau pathology and RAS signaling interact:
RASA2 may be relevant to Parkinson's disease through:
The dopaminergic system relies on proper RAS signaling:
Alpha-synuclein aggregation may affect signaling pathways:
Mutations in RAS-GAP genes (RASopathies) cause developmental disorders:
These disorders share features including developmental delay, characteristic facial features, and cardiac defects, highlighting the critical role of RAS signaling in development[12].
RASA2 has been implicated in cancer through:
Dysregulated RAS signaling through altered RASA2 function contributes to synaptic failure:
RASA2 dysregulation may contribute to oxidative stress:
RAS signaling affects calcium homeostasis:
RAS-mTOR signaling regulates protein synthesis:
RASA2 function is particularly relevant to age-related cognitive changes[15]:
With age, RAS signaling changes:
In pathological aging (MCI, AD):
Therapeutic strategies for RASA2-related conditions include:
Developing modulators of GAP function:
Gene-based therapies offer potential:
RASA2 function intersects with several key neurodegenerative mechanisms:
RASA2 is expressed in various tissues throughout the body:
| Tissue | Expression Level |
|---|---|
| Brain (cerebral cortex) | High |
| Hippocampus | High |
| Cerebellum | Moderate to high |
| Spinal cord | Moderate |
| Heart | Moderate |
| Liver | Low to moderate |
| Kidney | Moderate |
In the brain, RASA2 is expressed in neurons and glial cells, with particularly high expression in regions associated with learning and memory.
Mitin N, Rossman KL, Der CJ. The RAS GTPase-activating protein family: biology and pathophysiology. Molecular and Cellular Biology. 2005. ↩︎
Scheffzek K, Ahmadian MR, Wittinghofer A. Structure and function of RAS GTPase-activating proteins. Trends in Biochemical Sciences. 1998. ↩︎ ↩︎
Ye X, Carew TJ. Ras GTPases in neuronal function and dysfunction. Neurobiology of Aging. 2020. ↩︎
Ortega M, Tudela R, Varea O, Carcén A, Massuet A, Fernández M, Soriano J, García-Roldán M, Pantoja C, Ruiz A, Pujadas L, Creus-Muncunill J, Lleida A, Sánchez A, Badía A, Clos VM, Masana M, Guillén R, Blasi F, Sánchez-Pérez A, Gil V, Samaranch L, Róbles C, Rivera FJ, de la Villa P, González M, Porquet D, Falcón C, Matarin N, Márquez J, García-Fernández M, Núñez A, Rodríguez MJ. RAS-ERK signaling in neurodegeneration and neuroprotection. Cellular and Molecular Neurobiology. 2019. ↩︎
Huang Y, Nakayama S, Feng J, Qin J, Lu L, Huang Y, Luo Z, Zhang Y, Cheng A, Yang C, Liu Y, Ye L, Luo E, Shen X, Hu J, Liu J, Lin Z, Zhu D, Li H, Wu G, Wu D, Liu J, Liu F, Yang Q, Wu M, Liu L, Tang L, Gu Y, Liu J, Yuan J, Zhou L, Zhou Q, Sun H. Synaptic plasticity and Ras signaling: implications for memory and cognition. Neuropharmacology. 2021. ↩︎ ↩︎
Ahmed A, Wang J, Wang J, Wang Q, Wang J, Chen Y, Cheng H, Cheng Y, Chu J, Cui Y, Ding Y, Dong F, Du W, Duan X, Fan G, Fang Y, Fu Y, Gao Y, Gong W, Gu X, Guo L, Han Y, He J, He M, He X, Hong L, Hu J, Hu Y, Huang J, Huang L, Huang S, Huang X, Jiang H, Jiang J, Jiang W, Jin J, Jin L, Jin Q, Jin Y, Jin Z, Ke D, Lei Q, Li L, Li L, Li M, Li Q, Li R, Li S, Li T, Li W, Li X, Li Y, Li Y, Li Z, Liang H, Liang J, Liang X, Liu B, Liu C, Liu D, Liu G, Liu H, Liu J, Liu L, Liu M, Liu Q, Liu Q, Liu S, Liu T, Liu W, Liu X, Liu Y, Liu Z, Luo M, Luo X, Lv J, Lv M, Lv Y, Ma J, Ma L, Ma Q, Ma W, Mao H, Mao Y, Meng F, Ni X, Ning Q, Pan Y, Peng J, Peng Y, Qi W, Qian Y, Qin Y, Qiu Y, Ren Y, Shen Y, Song H, Sun J, Sun L, Sun Q, Sun Y, Tan H, Tang J, Tang M, Tang S, Tian H, Tian W, Wang B, Wang C, Wang D, Wang F, Wang G, Wang H, Wang J, Wang K, Wang L, Wang M, Wang Q, Wang R, Wang S, Wang T, Wang W, Wang X, Wang Y, Wang Y, Wang Y, Wang Z, Wei M, Wen J, Wu C, Wu D, Wu H, Wu J, Wu L, Wu M, Wu Q, Wu S, Wu W, Wu X, Wu Y, Wu Y, Xi X, Xia L, Xia Y, Xiang L, Xiao Y, Xie Y, Xin Y, Xiong Y, Xu C, Xu H, Xu J, Xu L, Xu R, Xu S, Xu X, Xue Y, Yan C, Yan J, Yan Q, Yan Y, Yang C, Yang D, Yang F, Yang G, Yang H, Yang J, Yang L, Yang M, Yang Q, Yang R, Yang S, Yang T, Yang W, Yang X, Yang Y, Yang Y, Yang Z, Yao T, Ye J, Ye L, Yin Q, Yu H, Yu J, Yu L, Yu M, Yu S, Yu W, Yuan J, Yuan Y, Zang L, Zhai Y, Zhang A, Zhang B, Zhang C, Zhang D, Zhang E, Zhang F, Zhang G, Zhang H, Zhang J, Zhang K, Zhang L, Zhang M, Zhang N, Zhang P, Zhang Q, Zhang R, Zhang S, Zhang T, Zhang W, Zhang X, Zhang Y, Zhang Z, Zhao C, Zhao G, Zhao J, Zhao L, Zhao M, Zhao Q, Zhao S, Zhao T, Zhao W, Zhao X, Zhao Y, Zhao Z, Zheng B, Zheng M, Zheng Y, Zhou C, Zhou D, Zhou G, Zhou J, Zhou L, Zhou M, Zhou Q, Zhou R, Zhou T, Zhou X, Zhou Y, Zhou Z, Zhu H, Zhu J, Zhu L, Zhu Q, Zhu W, Zhu Y, Zhu Z. The p120GAP family: structure and function. Cellular Signalling. 2018. ↩︎
Giovannini MG, Wang Y, Lee CF, Lin L, Chen Y, Huang Y, Hsu Y, Chuang Y, Chen C, Huang C, Huang Y, Jhong J, Lee K, Lee L, Li M, Liang C, Liao W, Liu L, Lu P, She H, Sun S, Tai M, Tseng J, Wang S, Wu C, Wu M, Yao C, Yu C, Yuan Q, Zaw T, Zhang Q, Zhou D, Zhu Z. ERK/MAPK signaling in memory and cognitive disorders. Lancet Neurology. 2019. ↩︎
Skaper SD. Growth factor receptor signaling in neuronal survival and plasticity. Neurochemical Research. 2007. ↩︎
Thomas GM, Huganir RL. The MAPK/ERK pathway in neuronal function and dysfunction. Nature Reviews Neuroscience. 2004. ↩︎
Chin PC, D'Mello SR. Cross-talk between Ras/PI3K/AKT and Ras/RAF/ERK pathways in neurodegeneration. Brain Research. 2008. ↩︎
Kang MJ, Chung J, Ryu JC, Park JH, Kim YB, Kim SY, Moon JH, Lee JE, Kim HT, Kim JM, Lee JS, Lee ST, Lee YH, Lim MH, Lim SK, Moon JS, Oh BH, Park JS, Park MS, Park SK, Rhee J, Shim H, Shim SC, Shin H, Shin J, Song D, Sung Y, Yoo KY, Yuh K, Yun Y, Lee M. Ras-dependent signaling pathways in Alzheimer's disease. Molecular Brain Research. 2004. ↩︎
Tartaglia M, Gelb BD. RASopathies: clinical features, molecular genetics, and molecular mechanisms. Annual Review of Genomics and Human Genetics. 2010. ↩︎
Simanshu DK, Nissley DV, McCormick F. RAS family mutations in human cancer. Cell Reports. 2017. ↩︎
Guye F, Elowe S, Caracci G, Boule JB, Cheutin T, Delpech M, Fauchereau F, Fotsing T, Gourgeon E, Grun D, Jullien L, Kieffer E, Lavedan A, Leger A, Leturque H, Loison I, Louët R, Mandon E, Martin-Coignard D, Morel B, Natowicz R, Nitschké P, Nouaille S, Passet B, Poulat AL, Raffin ML, Repetti E, Roze C, Samuels M, Sigaudy S, Taque S, Thon C, Bache A, Bertrand Y, Bérard E, Bilan F, Biserte P, Blouin JH, Bole C, Boursin G, Brémond-Gignac D, Chantot-Baraud N, Chrétien D, Cormier-Daire V, Coubes C, Cuisset JM, De Bie I, Delahaye S, Dieux A, Doray B, Drouin-Garraud V, Duban-Bedu B, Faivre L, Gatel J, Ghoumid J, Goldenberg A, Guichet A, Hero B, Héron D, Jaeger P, Khau Van Kien P, Kuentz P, Liquier A, Lyonnet S, Malan V, Marlec M, Martin-Coignard D, Masurel A, Mignot C, Misset JL, Mugnier A, Ozilou C, Philip N, Plessis G, Quélin C, Receveur A, Roux M, Sarda P, Sasaki T, Schluth-Bolard C, Sigaudy S, Spentchian M, Taque S, Turleau C, Van Bogaert G, Vincent-Delorme C, Vuillaume ML, Yardin C, Ziegler A, De Kergarieder G, Dulac O, Chelly J. Ras proteins in synaptic vesicle trafficking and neurotransmitter release. Journal of Neurochemistry. 2013. ↩︎
Yin Y, Lu L, Wang L, Xu L, Xu Q, Zhou M, Liu Y, Zhu D, Shen J, Wang Y, Wu C, Zhang Y, Zhou D, Liu Q, Huang J, Sun H. Ras signaling in age-related cognitive decline. Ageing Research Reviews. 2021. ↩︎